Clathrin structure characterized with monoclonal antibodies. II. Identification of in vivo forms of clathrin by unknown
Clathrin Structure Characterized with Monoclonal 
Antibodies. 
II.  Identification of In Vivo Forms of Clathrin 
FRANCES M.  BRODSKY 
Becton Dickinson Immunocytometry  Systems, Mountain  View, California 94039 
ABSTRACT  Clathrin was isolated from detergent-solubilized,  biosynthetically  radiolabeled cells 
by  immunoprecipitation  with  anti-clathrin  monoclonal  antibodies.  Immunoprecipitates  ob- 
tained  after  pulse-chase labeling demonstrated  that after  biosynthesis the LCa light chain of 
clathrin  could  be found  either complexed  to heavy chain  or in a free  pool  (not associated 
with  heavy chain)  which  decreased steadily  over  time.  More  than  half  of  the  free  LCa 
disappeared within the first hour after biosynthesis, but some was still detectable after several 
hours.  Incorporation  of clathrin  LCa  light  chain  and  heavy chain  into  coated  vesicles was 
coordinate and increased up to 4 h after biosynthesis. Comparison of these kinetics suggested 
that once  incorporated  into coated  vesicles, LCa and  heavy chain  did  not dissociate, even 
during depolymerization of the vesicle. There was also little  apparent degradation of clathrin 
found  in  coated  vesicles for  up to 22  h after  biosynthesis.  Immunoprecipitation  with anti- 
clathrin  monoclonal  antibodies was carried out after fractionation  of continuously radiolabeled 
cell lysates using two different  sizing columns. These experiments  indicated that the triskelion 
form of clathrin  that has been isolated from  coated vesicles in vitro also exists in vivo.  They 
also confirmed the existence of a transient but detectable  pool of newly synthesized free LCa 
light chain. 
Coated pits and coated vesicles are the structures that result 
from membrane invagination during endocytosis and intra- 
cellular membrane translocation (1). To form these organelles, 
the protein clathrin polymerizes at the membrane surface (2). 
After formation of an endocytic coated vesicle,  the clathrin 
depolymerizes within  a  few minutes,  and the resulting un- 
coated vesicle (endosome) is acidified (3-5). This sequence of 
events suggests that  within  a  cell  there  must be a  pool of 
depolymerized  clathrin  in  equilibrium  with  polymerized 
clathrin. The amount of depolymerized clathrin detectable in 
the  cytoplasm  seems  to  vary  depending  on  the  cell  type 
examined. It has been demonstrated that in some cell types 
up  to  70%  of the  clathrin  in  the  cell  is  not  membrane 
associated (6).  However, in other cell types large patches of 
plasma membrane-associated clathrin have been observed (2, 
7),  and it has been proposed that the clathrin subunits rear- 
range  on  the  membrane  to  form  coated  pits  and  initiate 
internalization (2). 
One question raised by these data is, What is the molecular 
form of the clathrin subunits involved in the polymerization- 
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depolymerization cycle in  vivo? Clathrin  is composed of a 
heavy chain of 180 kD and two light chains, LCa and LCb, of 
32-38 kD (8-10). It has been shown that the molecular unit 
of clathrin that is stripped off coated vesicles under nonphys- 
iological conditions is a "triskelion" consisting of three clath- 
rin heavy chains and three light chains (9-11). These struc- 
tures apparently have a random distribution of the two forms 
of clathrin light chain (l 2). Thus far, no evidence has been 
presented to demonstrate that disassembled clathrin in vivo 
also has this structure. The possibility remains that free pools 
of clathrin heavy chain or light chains or even heavy chain- 
light  chain  monomers  may  exist  in  vivo,  and  that  these 
regulate coated vesicle assembly directly or indirectly by reg- 
ulating triskelion assembly. 
In this study, the form of in vivo clathrin has been exam- 
ined.  The monoclonal anti-clathrin  antibodies described in 
the companion article have been used to immunoprecipitate 
biosynthetically radiolabeled clathrin present in cells in tissue 
culture (13). Pulse-chase labeling was used to examine assem- 
bly of clathrin subunits after biosynthesis. Fractionation  of 
2055 labeled cell lysate was used to determine the size of  the clathrin 
molecules involved in steady state polymerization and depo- 
lymerization. These experiments demonstrated the existence 
of a transient pool of free LC~ light chain, after biosynthesis, 
as well as the existence of clathrin triskelions in vivo. 
MATERIALS  AND  METHODS 
Cell Lines, Media, and Reagents 
The LB cell line, an Epstein Ban" virus-transformed human B cell line, was 
a gift from V. Engelhard (University of Virginia, Charlottesville). The BL-3 cell 
line, grown from bovine leukemia cells, was a gift from G. Theilen (University 
of  California, Davis). These cells were grown in RPMI  1640 with 10% fetal calf 
serum and  no  antibiotics.  For biosynthetic  radiolabeling,  amino acid-free 
media were prepared  from the RPMI-1640  Select-Amine kit (No.  300-7402, 
Gibeo  Laboratories, Grand Island, NY) and used with 5% dialyzed fetal calf 
serum. The Anti-Leu 4, Anti-Leu  10, and anti-Igh5b monoclonal  antibodies, 
used as control antibodies of the IgG~ isotype, were obtained  in purified form 
from Becton  Dickinson  Immunocytometry Systems. Their respective target 
antigens  are  a  human T  cell surface glycoprotein,  a  human B cell surface 
glycoprotein (HLA-DQ), and an allotypic determinant  of mouse IgD (14-16). 
For immune complex  formation,  sheep anti-mouse  IgG (Cappel 0211-1744, 
Cappel  Laboratories,  Cochranville,  PA) was used. All other antibodies  were 
purified from mouse ascites fluid as previously described (17). Fixed Staphylo- 
coccus aureus (Staph A)  ~  bacteria were from The Enzyme Center (Boston, MA). 
IMMUNE  COMPLEX  METHOD  (21,  22):  Immune complexes  were 
formed with 200 ~g purified monoclonal antibody and 300 #l sheep anti-mouse 
immunoglobulin  (specific antibody at 7 mg/ml) and washed in 50 mM Tris, 
pH 8.0, 200 mM NaCl,  l mM EDTA, 0.5% NP40 (complex buffer). Aliquots 
of  cell lysate were preincubated with immune complexes formed from a control 
antibody  (anti-Igh5b).  These  were removed  by  centrifugation,  and  specific 
immune complexes were added. After incubation for 1 h at 4°C, lysate contain- 
ing specific immune complexes was layered on a step gradient that consisted, 
from bottom to top, of 1 ml 40%  sucrose,  l0 mM Tris, pH 8.0,  l  ml 30% 
sucrose, 0.2% NP40,  l0 mM Tris, pH 8.0,  l  ml 20%  sucrose, 0.5  M NaCl, 
0.2% NP40,  t0 mM Tris, pH 8.0, and 1 ml 10% sucrose, 0.5% NP40,  10 mM 
Tris, pH 8.0, and centrifuged at 2,000 g in a swinging bucket rotor. The pelleted 
complexes were washed  once  in  complex  buffer  and then dissolved in the 
sample buffer used for electrophoresis. 
Electrophoresis and Autoradiography 
SOS PAGE was carried out according to the method  of Laemmli (23). All 
gels were 10% acrylamide. Gels were stained with Coomassie Brilliant Blue R 
and, after destaining (13), treated with Enlightening (New England Nuclear). 
Gels were dried and exposed to XAR-5 Kodak film using an intensifying screen 
(Dupont Lightening Plus, DuPont Photo Products Division-X-Ray, Burbank, 
CA). Molecular weight markers (Pharmacia  Fine Chemicals, Piscataway, NJ) 
used were phosphorylase b (94 kD), bovine serum albumin (67 kD), ovalbumin 
(43 kD), carbonic anhydrase (30 kD), soybean trypsin inhibitor (20. l kD), and 
a-lactalbumin  (14.4 kD). 
Biosynthetic Radiolabeling 
C  O  N  Z  I S U  O  U  S L  A  B  E  L  I N  G ( 18 ) :  Lymphoid cell line cells were washed 
once in RPMI  1640 medium without the amino acid used for labeling. They 
were resuspended at 2 x  l06 cells/ml  in fresh amino acid free-medium and 
incubated for 30 rain at 37"C, and then the radioactive amino acid at  1 mCi 
per 2 x  l07 cells was added. [3~S]Methionine  (>800 Ci/mmol, No. NEG-009T, 
New  England  Nuclear,  Boston,  MA), [3H]leucine  (120-190  Ci/mmol, 
TRK.683,  Amersham Corp., Arlington Heights, IL) or [3H]lysine (80-1 l0 Ci/ 
retool, NET-376, New England Nuclear) were used. After 4 h of incubation at 
37°C, cells were washed once in cold phosphate-buffered  saline, pH 7.4, and 
then resuspended at 2 x  l0  T  cells/ml in buffer I (10 mM Tris, pH 7.3, 1 mM 
MgCI2, 0.5% Nonidet  P-40 [NP40], 0.005%  phenylmethylsulfonyl  fluoride) 
(19), buffer  II (t0 mM Tris,  pH 8.0, 200 mM NaCI,  1 mM EDTA,  1 mM 
EGTA, 0.5 % NP40, 0.005% phenylmethylsulfonyl  fluoride), or buffer III (10 
mM 2-(N-morpholino)ethane  sulfonic acid, pH 6.2, 200 mM NaCl, 2.5 mM 
MgCI2,  2  mM  CaCl2, 0.5% NP40,  0.005% phenylmethylsulfonyl  fluoride). 
After 30 rain  at 4°C, solubilized cells were microfuged for 15  rain,  and the 
pellet was discarded. 
PULSE-CHASE LABELING (20):  Lymphoid cell line cells (4 X 107)were 
washed once in methionine-free  medium, resuspended at 4 x  10~/ml in fresh 
methionine-free  medium,  and incubated  at 37"(? for 30-60  rain.  Cells were 
then centrifuged, resuspended at 4 x  l0  T  cells/ml in methionine-free medium, 
and 2 mCi [3~S]methionine  was added. After 10 rain at 37°C, chase medium 
(RPMI-1640,  10% fetal calf serum, 75 t,g/ml L-methionine) was added, and 4 
x  l06 cells were removed for solubilization at designated chase times, with the 
culture kept at 37°C. Cells were solubilized as above, without washing, in either 
buffer  I or buffer  II. Results obtained  with  both solubilization  buffers were 
identical. 
TRICHLOROACETIC ACID (TCA)  PRECIPITATION:  Theamount of 
radioactivity incorporated  into protein during biosynthetic labeling was deter- 
mined by precipitation  of an aliquot of cell lysate with 10% TCA. Precipitates 
were resuspended in solubilization buffer and counted  in Aquasol (New Eng- 
land  Nuclear) in a scintillation counter,  This procedure was used to monitor 
the pulse-chase labeling and confirm that no further radioactivity  was incor- 
porated into protein after the chase medium was added. 
Immunoprecipitation 
STAPH  A METHOD (19):  Aliquots of cell lysate were preincubated  with 
normal rabbit  serum and  Staph  A,  which  was removed  by centrifugation, 
Pretreated lysate was then incubated with specific MAb for 1 h at 4"C. Rabbit 
anti-mouse  immunoglobulin  serum and Staph A were used to isolate antibody 
antigen complexes. Buffers, washing procedures, and sample elution were the 
same as those described previously (18, 19). 
J Abbreviations used in thispaper. MAb, monoclonal antibody; NP40, 
Nonidet P-40; Staph A, fixed Staphylococcus  aureus bacteria. 
Column Chromatography 
Columns (0.9 cm x  30 cm) of Ultrogel AcA 22  (LKB Instruments Inc., 
Gaithersburg,  MD)  or Sephacryl  S-1000 (Pharmacia  Fine  Chemicals) were 
equilibrated in buffer II without NP40 for calibration. Protein standards used 
for calibration  were molecular  weight markers (Bio-Rad No.  151-901 at 3.6 
mg/ml, Bio-Rad Laboratories, Richmond,  CA), elathrin triskelions at 200 ug/ 
ml, and coated vesicles at ~2 mg/ml in column buffer with 0.5  mg/ml blue 
dextran. A l-ml sample of each protein standard was applied to each column, 
and l-m1 fractions were collected. The columns were then equilibrated in buffer 
II with l mg/ml ovalbumin and used repeatedly for fractionation of 1 ml lysate 
from 2 x  l07 cells labeled with [35S]methionine for 4 h. The lysate applied to 
the column was preincubated  with normal rabbit serum and Staph A or with 
control immune complex. The l-m1 fractions collected were also preincubated 
with normal rabbit serum and Staph A or control immune complex and then 
divided into two aliquots for immunoprecipitation  with specific and control 
monoclonal  antibodies. For the AcA 22 column runs, the fraction containing 
the peak of blue dextran was noted, and the preceding fraction was counted as 
fraction I. For the S-1000 column separations of radioactive cell lysate, 5 ~,l of 
each fraction was suspended in Aquasol and counted in a scintillation counter. 
The  first  fraction  containing  radioactivity  was counted  as  fraction  I.  This 
corresponded to fraction  l of  the calibration runs based on the position of blue 
dextran, the number of fractions collected after the sample was loaded, and the 
bed volume  of the column.  The clathrin  triskelions and coated  vesicles used 
for calibration  were purified  from bovine  brain  as described by Pearse and 
Robinson (24). 
RESULTS 
Isolation of Biosynthetically 
Radiolabeled Clathrin 
To determine the feasibility of studying in  vivo forms of 
clathrin, three MAbs were tested for their ability to immu- 
noprecipitate clathrin from detergent-solubilized, biosynthet- 
ically radiolabeled cells.  The  specificities of the  antibodies 
used in this study are listed in Table I. A human B cell line 
(LB) was grown for 4 h in the presence of [3SS]methionine  or 
[3H]lysine  in  appropriately  depleted  tissue  culture  media. 
These cells were solubilized in a detergent-containing buffer 
(buffer I), commonly used  for solubilizing biosynthetically 
labeled cell  surface glycoproteins. Fig.  1 shows the antigens 
immunoprecipitated from [aSS]methionine  LB cell lysate us- 
ing the Xl6, X19, and X22 MAbs and Staph A. Results from 
the [3H]lysine-labeled cells were identical, as were results using 
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Clathrin binding specificity*  Species specificity 
Coated 
MAb  Subunit  Triskelions  vesicles  Bovine  Human  Mouse 
CVC.6  +  (LCa)  +  +  +  -  NT 
X16  +  (LCa)  -  -  +  +  + 
Xl 9  +  (heavy chain)  +  +  +  +  NT 
X22  +  (heavy chain)  +  +  +  +  NT 
* MAb reactivity summarized here is based on specificity in immunoprecipitation  or immunoaffinity experiments. Reactivity is indicated by +. Lack of reactivity 
is indicated by -. NT, not tested. 
FIGURE  I  Clathrin  isolated  by  immunoprecipitation from  an  35S- 
labeled human  B cell  line (LB).  Anti-clathrin  MAbs  X16,  X19, and 
X22, and control MAb anti-Leu 4  were combined with aliquots of 
NP40-solubilized LB cells, labeled for 4 h with [3SS]methionine. The 
antibody-antigen complexes were isolated with  rabbit anti-mouse 
immunoglobulin serum and Staph A, analyzed by SDS  PAGE, and 
the  antigen was visualized  by  autoradiography.  Each  lane  shows 
the antigen immunoprecipitated by the antibody indicated at the 
top of the  autoradiograph. The  specificities of the antibodies are 
listed in Materials and Methods and Table I. The migration distance 
of standard proteins of known molecular weight and human brain 
clathrin polypeptides are indicated at the left of the autoradiograph. 
The position of Lea light chain isolated from LB cells is indicated at 
the right. 
solubilization buffers II and III, designed to stabilize triskel- 
ions  and  coated  vesicles,  respectively.  The  XI6  antibody, 
which  immunoprecipitates free LC. but  not  intact clathrin 
triskelions, isolated LCa from the cell lysate. This immuno- 
precipitated LC~ was not associated with clathrin heavy chain. 
Note that the  molecular weight of the  immunoprecipitated 
lymphoid LC~ is lower than that of  human brain clathrin LC., 
used as a molecular weight marker, as would be expected for 
nonbrain clathrin (25). The fainter band of -40 kD also seen 
in the X 16 immunoprecipitate was not a  consistent compo- 
nent in repeated immunoprecipitations, and its significance 
is unclear.  The clathrin  immunoprecipitated by anti-heavy 
chain  antibodies X19  and  X22  appeared to  contain  heavy 
chain and LC, light chain, but a band at the expected molec- 
ular  weight  for  LCb  light  chain  was barely detectable.  To 
investigate this result, XI9 and X22 were used to immuno- 
precipitate  clathrin  from  cells  labeled  with  [3H]lysine  or 
[3H]leucine for 3-5 h or from cells labeled with [35S]methio- 
nine for as long as 24 h. In some of these immunoprecipitates 
the LCb band was more clearly visible than in the examples 
shown in Fig.  1, but it was always lighter than the LC, band. 
Its presence did not correlate with the amino acid used for 
labeling, the length of the labeling period, or whether the cell 
lysate had  been frozen before immunoprecipitation,  which 
might  have caused  preferential  degradation.  The  X19  and 
X22 immunoprecipitates also contained a series of polypep- 
tides from 60-150 kD, some of which are presumably clath- 
rin- or coated vesicle-associated proteins. Others correspond 
to  bands  seen  in  the  immunoprecipitate  obtained  with  a 
control antibody of the same isotype, Anti-Leu 4. 
This initial experiment established that anti-clathrin MAbs 
could be used to immunoprecipitate biosynthetically radio- 
labeled clathrin from cell lysate to study its form in vivo. The 
pulse-chase experiments described below were carried out to 
determine whether the free LCa immunoprecipitated by the 
X 16 antibody represents a diminishing pool of newly synthe- 
sized LCa or is derived from a regenerating stable pool of free 
LCa.  Experiments on  gel  filtration  of cell  lysate were then 
carded  out  to  determine  the  size  of the  heavy chain-LCa 
complex immunoprecipitated by X 19 and X22 and to see if 
a separate pool of free LCa was immunoprecipitated by X 16. 
Fate of Clathrin Polypeptides After Biosynthesis 
The stability of the intracellular pool of LCa detected by 
the X 16 MAb was determined by immunoprecipitation after 
a  pulse-chase labeling.  Cells were  labeled  for  10  min  with 
[35S]methionine  and then diluted in medium containing an 
excess of unlabeled methionine (chase medium). Aliquots of 
cells were solubilized at the time of dilution  and at specific 
intervals  thereafter.  The  XI6  (anti-LC,),  X22  (anti-heavy 
chain) and control MAbs were combined with these lysates, 
and immunoprecipitated antigen was analyzed by SDS PAGE 
and autoradiography. This experiment was carded out several 
times  using  the  human  B  cell  line,  LB,  and  the  bovine 
leukemia line, BL-3. The results were the same for both cell 
lines, and representative experiments are shown in Fig. 2. The 
X 16 and anti-Leu 10 immunoprecipitates were obtained using 
preformed immune complexes according to the  method of 
van Agthoven et al. (21).  The X22 and anti-Leu 4 immuno- 
precipitates were  isolated  with  Staph  A.  The  first  method 
produced less background immunoprecipitation, as indicated 
by the arrows at the right of the anti-Leu 10 and anti-Leu 4 
BRODSKY  Characterization of Clathrin Structure II.  2057 FIGURE  2  Clathrin  biosynthesis  in  BL-3 and  LB  cells  analyzed by pulse-chase  labeling and  immunoprecipitation. Cells  were 
labeled for  10 min with [~SS]methionine. Then chase medium, containing excess unlabeled methionine, was added at time 0. 
The MAbs indicated below each  panel were used to immunoprecipitate antigen from aliquots of cells solubilized at the chase 
times indicated at the top of each panel. The prime symbol stands for minutes. Each panel shows an autoradiograph of SDS 
PAGE analysis of the immunoprecipitates.  At the left of each panel are the migration positions of the molecular weight markers 
used. At the right of the X16 and X22 panels the immunoprecipitated clathrin components are indicated. HC, heavy chain. At 
the right of the Anti-Leu 10 and Anti-Leu 4 panels the background bands are indicated. The X16 and anti-Leu 10 immunoprecip- 
itates  are  from  pulse-labeled  BL-3 cells  and  were  obtained  by  the  immune  complex  method.  The  X22  and  anti-Leu  4 
immunoprecipitates  are from pulse-labeled LB cells and were obtained by the Staph A method. 
autoradiographs.  However,  the  second  method  gave  more 
efficient results with the X22 antibody. The position of the 
LCa polypeptides immunoprecipitated by X 16 is indicated at 
the  right  of the  autoradiograph.  The  amount  of free  LCa 
immunoprecipitated began to decrease by 30 min, and grad- 
ual  reduction  continued  for several hours.  By  l  h  of chase 
time, less than half of the LCa detected immediately after the 
pulse labeling was present. However, some free LCa could still 
be immunoprecipitated 4 h after biosynthesis, and it was just 
barely detectable for as long as 7 h  after chase medium was 
added.  Additional  experiments  showed  that  it  completely 
disappeared  by  8  h.  The  amount  of clathrin  heavy chain 
immunoprecipitated by X22 increased up to 4 h after chase 
medium was added and then leveled off. The amount of co- 
precipitated LCa increased with the same kinetics. Although 
some newly synthesized LCa could be found in a  free pool 
after biosynthesis, a faint band at the molecular weight of LCa 
could be seen associated with  heavy chain  in  the  X22  im- 
munoprecipitates, within l0 min after synthesis. The presence 
of LC~ associated with heavy chain at the time chase medium 
was added  was confirmed  by longer exposure of the  X22 
autoradiograph. 
Sizing Clathrin Molecules in Cell Lysates 
To determine the size of clathrin molecules present in vivo, 
columns  (0.9  x  30  cm)  composed  of gel  filtration  media 
Ultrogel  AcA  22  and  Sephacryl  S-1000  were  used.  These 
columns were calibrated with known molecular weight mark- 
ers, with clathrin triskelions purified from bovine brain, and 
with bovine brain coated vesicles,  which were applied to the 
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calibration, radiolabeled cell lysates were applied to the col- 
umns  and  fractions were collected.  The  MAbs  X22  (anti- 
heavy chain), CVC.6 (anti-LCa in triskelions), and X l6 (anti- 
free LCa) were used to immunoprecipitate clathrin from these 
fractions and  thereby  determine  the  elution  position  of in 
vivo  clathrin.  X22  and  CVC.6  were  chosen  because  they 
reacted  with  clathrin  in  triskelion  and  coated  vesicle  form 
when tested  as  immunoaffinity columns.  X16  was used  to 
confirm the existence  of a  free pool of the light chain.  The 
bovine  lymphoid  cell  line,  BL-3,  was used  for radiolabeled 
lysate preparation because  the  CVC.6  antibody,  which im- 
munoprecipitates LCa associated with clathrin heavy chain, 
reacts  only  with  bovine  clathrin.  In  a  typical  experiment, 
lysate was applied  to  a  column and  the  fractions collected 
were  immunoprecipitated  with  a  specific  antibody  and  a 
control antibody. The fractions analyzed in the experiments 
described  below  are  all  numbered  starting  with  the  void 
volume and therefore represent equivalent elution positions 
off of each column. 
Fig.  3  shows results obtained with the AcA 22  sizing col- 
umn. The calibration profile, seen in Fig. 3A, shows resolution 
of molecular weight  markers in  the  17  to  670  kD  range. 
Calibration with purified clathrin triskelions and coated ves- 
icles showed that both species co-eluted in the void volume 
with blue dextran, even though the buffer was at pH 8.0 and 
contained  chelating  agents  to  stabilize  the  triskelion  form 
(12).  Lysate was applied  to the column, and fractions from 
FIGURE  3  The  size  of  in  vivo 
clathrin examined by AcA 22 frac- 
tionation of radiolabeled cell ly- 
sate. Protein standards  of known 
molecular weight were separated 
on  a  column  (0.9  x  30  cm)  of 
UItrogel AcA 22, and 15 1-ml frac- 
tions were collected. The absor- 
bance  profile  of  the  column 
eluate is shown in A. The elution 
position of each protein was con- 
firmed by SDS PAGE analysis. The 
proteins applied to  the  column 
were thyroglobulin (670 kD),  IgG 
(158 kD), ovalbumin (44 kD), my- 
oglobin (17 kD), and vitamin B-12 
(1.4 kD).  Purified clathrin triskel- 
ions and coated vesicles eluted in 
the void volume (not shown). Cell 
lysate (1  ml) prepared from [3sS]- 
methionine-labeled BL-3 cells  (2 
x  107  )  was  fractionated  on  the 
same  UItrogel  AcA  22  column, 
and corresponding fractions were 
collected.  These  fractions  were 
divided  into  two  aliquots  and 
used  for  immunoprecipitation 
with  anti-clathrin  and  control 
MAb anti-Leu 10. Immunoprecip- 
itates  were  analyzed  by  SDS 
PAGE  and  autoradiography.  B 
shows  the  clathrin  heavy  chain 
(HC) region of the autoradiograph 
of  X22  immunoprecipitates.  C 
shows the LCa light chain region 
of the autoradiograph of X16 im- 
munoprecipitates. D  shows  the 
region of  the  autoradiograph ot 
anti-Leu  10  immunoprecipitates 
corresponding to  B  and  C.  Im- 
munoprecipitates  shown in C and 
D  were obtained from the same 
fractions.  The  control  immuno- 
precipitates for  the  results  ~n  i; 
were identical to those shown in 
D.  The  migration  of  molecular 
weight markers is indicated at the 
right of each panel. 
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anti-Leu  10. Fractions from a second run were immunopre- 
cipitated  with  CVC.6  and  anti-Leu  10.  A  third  run  was 
immunoprecipitated with X 16 (Fig. 3C) and anti-Leu 10 (Fig. 
3D).  Since  the  anti-Leu  10  results  were  similar,  only  one 
example  is  shown.  The  CVC.6  and  X22  antibodies  both 
immunoprecipitated  clathrin  (heavy  chain  and  LCa  light 
chain) from the fractions containing blue dextran. The peak 
trailed into the column, but there was no additional peak of 
heavy chain clathrin precipitated at a lower molecular weight 
than triskelions. The X 16 MAb immunoprecipitated free LCa 
light chain in a separate peak of lower molecular weight than 
triskelions. 
Since purified coated vesicles eluted off the AcA 22 column 
at the same position as clathrin triskelions, it was of interest 
to repeat these experiments on a column that would distin- 
guish  between  triskelions  and  coated  vesicles.  The  S-1000 
column was used for this purpose. Calibration of this column 
is shown in Fig.  4.  The peak of triskelion elution was con- 
tained in fractions  10-12 (Fig.  4B), and the peak of coated 
vesicle elution was located in fractions 6-8 (Fig. 4C). Analysis 
of immunoprecipitates from two lysate runs on the S-1000 
column (Fig.  5) shows that the peak of clathrin isolated by 
the CVC.6 antibody (Fig. 5A) spanned the positions ofelution 
of the coated vesicle and triskelion peaks. The clathrin peak 
isolated by X22 (Fig. 5B) overlapped primarily with the coated 
vesicle peak. Again, the clathrin immunoprecipitated by both 
antibodies (CVC.6 and X22) contained heavy chain and LCa 
light chain.  Control autoradiographs (not shown) of immu- 
noprecipitates obtained with anti-Leu l0 from these fractions 
had essentially no bands in the heavy chain region. 
DISCUSSION 
In the experiments described above, anti-clathrin MAbs have 
been used to immunoprecipitate clathrin directly from cell 
FIGURE  4  S-1000  fractiona- 
tion of (A) standard proteins, 
(B)  clathrin  triskelions,  and 
(C) coated vesicles.  Protein 
standards  of known  molec- 
ular weight were separated 
on a column (0.9  x  30 cm) 
of Sephacryl  S-1000, and 15 
1-ml  fractions  were  col- 
lected. The absorbance pro- 
file of the column eluate is 
shown in A. The proteins ap- 
plied to the column were the 
same as described in the leg- 
end to  Fig. 3.  Their elution 
position  was  confirmed  by 
SDS  PAGE. Clathrin  triskel- 
ions (B) and coated vesicles 
(C),  purified  from  bovine 
brain,  were  applied to  the 
same Sephacryl  S-1000 col- 
umn.  Corresponding  frac- 
tions were collected, and a 
20-~1 sample of each fraction 
was analyzed by SDS PAGE. 
Gels were stained with Coo- 
massie  Blue  and  photo- 
graphed. The migration po- 
sitions of the clathrin heavy 
chain (HC)  and  light chains 
(LCa and  LCb) are  indicated 
at the left of B and C. 
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ation of radiolabeled cell lysate. Cell lysate (1  ml)  prepared from 
[35S]methionine-labeled  BL-3 cells (2 x  107)  was fractionated on the 
Sephacryl S-1000 column described in  Fig. 4, and  corresponding 
fractions  were collected. These  fractions  were divided  into two 
aliquots and used for immunoprecipitation with anti-clathrin and 
control MAb anti-Leu  10.  Immunoprecipitates were analyzed by 
SDS PAGE and autoradiography. A shows the region of the auto- 
radiograph of the CVC.6 immunoprecipitates  that contain the clath- 
rin  heavy chain (HC).  B shows  the corresponding region of the 
autoradiograph of X22 immunoprecipitates. These immunoprecip- 
itates were obtained from different sets of fractions collected after 
identical  lysate  fractionations.  The  bands  shown  are  unique as 
compared with those of autoradiographs of anti-Leu 10 immuno- 
precipitates from  the same fractions  (not shown).  The migration 
position of the molecular weight marker, phosphorylase b (94 kD), 
is shown at the left of both panels. 
lysates to examine the  forms of clathrin  that exist in  vivo. 
Using anti-clathrin heavy chain MAbs (X19  and X22) and 
an MAb (X 16) that immunoprecipitates LCa light chain only 
if it is not associated with heavy chain, it was demonstrated 
that the LCa light chain can be found associated with heavy 
chain or in free form. To determine the size of the immuno- 
precipitated structures and the kinetics of their intracellular 
existence,  immunoprecipitation  was  carried  out  after  cell 
lysate fractionation by column chromatography or after pulse- 
chase  labeling  of the  cells  used  to  prepare  lysates.  Lysate 
fractionation on a  column of Ultrogel AcA 22 showed that 
clathrin heavy chain associated with LCa light chain localized 
to the void volume, as determined by immunoprecipitation 
with anti-heavy chain MAb X22 and CVC.6, which prefer- 
entially  immunoprecipitates LC~ in  association with  heavy 
chain.  Both  antibodies reacted  exclusively with  clathrin  in 
this  peak.  Calibration  with  purified  triskelions  and  coated 
vesicles showed that both structures eluted in the void volume, 
demonstrating that triskelions that are -645 kD (9,  10) eluted 
at a higher apparent molecular weight, perhaps as a result of 
their unusual geometry. The X I6 MAb (anti-free LC~) iso- 
lated LCa light chain from a  separate peak, eluting at lower 
molecular weight. This elution zone corresponded to fraction- 
ation  of the  44-158-kD  protein  standards,  which  is  higher 
than would be expected for a single free light chain. However 
it has been shown previously that on a Spherogel TSK 3000 
column, free clathrin light chains run with an apparent mo- 
lecular weight of 90  kD  (26).  They appear to  have similar 
properties in this system. Lysate from cells labeled continu- 
ously for 4 h was then applied to a Sephacryl S-1000 column, 
which resolves purified coated vesicles from triskelions, run- 
ning at a position corresponding to their expected molecular 
weight on this particular column. The X22 MAb immuno- 
precipitated clathrin  primarily from the  elution  position of 
coated vesicles. The CVC.6 MAb isolated clathrin, which co- 
migrates with both coated vesicles and triskelions. Within the 
limit of the resolution of the AcA 22 and S-1000 columns, 
and the  specificities of the antibodies used,  no  other peaks 
containing clathrin heavy chain in association with light chain 
were identified. These results indicate that the triskelion and 
coated vesicle forms identified for depolymerized and polym- 
erized clathrin in vitro also exist in vivo. The results obtained 
with X16  suggest  that, in  addition,  a  pool of free LCa light 
chain can be found in vivo. 
One result that is still unexplained is the predominance of 
the LCa light chain seen in immunoprecipitates obtained with 
the anti-heavy chain MAbs, X 19 and X22. This is unexpected 
because the light chains of bovine brain clathrin purified in 
vitro apparently have a random distribution in their associa- 
tion with heavy chain in triskelions (12). A simple explanation 
is that lymphoid cell clathrin  might contain predominantly 
LCa light chain and that the 1:2 ratio of LCa/LCb light chain, 
found in brain tissue,  is not typical of other tissues (9,  10). 
However, the  variation in  amounts of immunoprecipitated 
LCb suggests that an additional factor may influence the LCd 
LCb ratio in immunoprecipitates. One possibility is that tri- 
skelions and even coated vesicles in vivo may have a nonran- 
dom distribution of the two light chains. More experiments 
on light chain quantitation in different tissues and the devel- 
opment of an anti-LCb MAb are needed to clarify the question 
of light chain distribution in vivo. 
Immunoprecipitation  after  pulse-chase  labeling  showed 
that the amount of free LCa immunoprecipitated by the X 16 
MAb  decreased  gradually  after  biosynthesis  but  could  be 
detected for as long as 7 h. Within  I h after biosynthesis the 
amount of free LCa detected was less than half of that detected 
just  after  pulse  labeling.  Parallel  experiments  with  X22 
showed that labeled clathrin heavy chain and light chain were 
increasingly incorporated into coated vesicles for up to 4  h. 
After 4  h,  the amount of labeled clathrin in coated vesicles 
dropped slightly  and then remained constant for at least 22 
h.  This indicates there is little turnover of the heavy chain 
and light chain involved in coated vesicle formation within a 
22-h period. The fact that the heavy chain and associated light 
chain appear in coated vesicles with similar kinetics suggests 
that they are either incorporated simultaneously or become 
associated  with  each  other  as  triskelions  before  assembly. 
Since the rate of free LCa disappearance was more rapid than 
that of coated vesicle formation, light chain and heavy chain 
probably form triskelions before assembly occurs. Comparing 
the kinetics of reduction of the free LCa pool with those of 
coated vesicle formation also suggests  that the association of 
LCa with heavy chain  is irreversible once the complex has 
been incorporated into a coated vesicle. This implies that LCa 
remains associated  with  heavy chain  when  coated  vesicles 
depolymerize. 
The kinetics of clathrin biosynthesis determined above were 
found to be equivalent in lymphoid cell lines derived from a 
bovine leukemia cell and an Epstein Barr virus-transformed 
human  B  cell.  Although,  it is  possible that  the  kinetics of 
clathrin  biosynthesis may vary among cell  types,  it  is  still 
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other proteins composed of multiple subunits. Class I histo- 
compatibility antigen heavy chain and #2-microglobulin light 
chain  associate within  15  min  after biosynthesis,  and  this 
association is required for expression on the cell surface (20, 
27).  Vimentin,  which  is  initially  synthesized  as  a  soluble 
cytoplasmic precursor, becomes completely associated with 
the  cytoskeleton by  polymerization into  intermediate  fila- 
ments within 2  h, and the soluble form has a  half life of 7 
rain  (28).  Most  newly synthesized a-spectrin  is  found in  a 
cytoplasmic pool; either the pool rapidly associates with the 
/~-spectrin  in the cytoskeleton, or the excess is degraded with 
a half-life of 45-60 min (29, 30). It is possible that, similar to 
a-spectrin,  LCa is synthesized in excess of heavy chain, and 
reduction  of the  free  pool  detected  by  X I6  indicates  the 
degradation rate of LCa that has not associated with heavy 
chain. It is also possible that the reduction of free LCa directly 
reflects the rate at which LCa becomes associated with heavy 
chain  and  is  therefore  no  longer  detectable  with  the  X16 
MAb. These two explanations will be resolved when methods 
for quantitive immunoprecipitation have been worked out. 
Further experiments will also be required to determine the 
kinetics of light chain-heavy chain association before coated 
vesicle formation, and whether a pool of heavy chain mono- 
mers or trimers (31) exists that might interact with the free 
light chain pool. Such investigations will become possible as 
more monoclonal antibodies with specificity for clathrin in 
different structural forms are produced. 
I thank B. Abrams and L. Kelley for technical assistance, G. Theilen 
and V. Engelhard for supplying cell lines, B. Summey for artwork, 
O.  Huff for manuscript preparation, and  P.  Parham for helpful 
discussions. 
Received for publication  17 April 1985, and in revised form 12 July 
1985. 
REFERENCES 
1.  Pearse,  B. M. F., and M. S. Bretscher.  1981.  Membrane recycling by coated vesicles. 
Annu. Rev. Biochem.  50:85-101. 
2.  Heuser, J.  1980. Three-dimensional visualization of coated vesicle formation in fibro- 
blasts.  J. Cell Biol.  84:560-583. 
3.  Wall,  D. A., G. Wilson, and A. L. Hubbard.  1980. The galactose-specific  recognition 
system of mammalian liver: the route of ligand internalization in rat hepatocytes.  Cell. 
21:79-93. 
4.  Willingham, M. C., and I. Past,an.  1980. The receptosome: an intermediate organelle  of 
receptor-mediated endocytosis in cultured fibroblasts.  Cell. 21:67-77. 
5.  Tycko, B., and F. R. Maxfield.  1982. Rapid acidification ofendocytic vesicles containing 
a2-macroglobulin.  Cell. 28:643-651. 
6.  Goud,  B.,  C.  Huet,  and  D.  Louvard.  1985. Assembled  and  unassembled  pools  of 
clathrin: a quantitative study using an enzyme immunoassay. J. Cell Biol.  100:521-527. 
7.  Aggeler,  J.,  and  Z.  Werb.  1982. Initial events during phagocytosis  by macrophages 
viewed from outside and inside the cell: membrane-particle interactions and clathrin. J 
Cell Biol. 94:613-623. 
8.  Pearse,  B. M. F.  1975.  Coated  vesicles  from pig brain: purification and  biochemical 
characterization. Z Mol. Biol.  97:93-98. 
9.  Kirchhausen,  T., and  S. C.  Harrison.  1981. Protein organization in clathrin  trimers. 
Cell. 23:755-761. 
10.  UngewickelI, E., and D. Branton. 1981.Assemblyunitsofclathrincoats.  Nature(Lond.). 
289:420-422. 
11.  Crowther,  R. A.,  and B. M. F.  Pearse.  1981. Assembly and packing of clathrin  into 
coats. Z  Cell BioL 91:790-797. 
12.  Ki~hhausen, T., S. C. Harrison, P. Parham, and F. M. Brodsky.  1983. Location and 
distribution of the light chains in clathrin trimers. Proc. NatL Acad.  Sci.  USA.  80:2481- 
2485. 
13.  Brodsky,  F.  M.  1985. Clathrin structure characterized with monoclonal  antibodies.  1. 
Analysis of multiple antigenic ~tes.  J. Cell Biol.  101:2047-2054. 
14.  Ledbetter,  J. A,, R. L. Evans, M, Lipinski, C. Cunningham-Rundles, R. A. Good, and 
L, A. Herzenberg. 1981. Evolutionary conservation of surface molecules that distinguish 
T  lymphocyte helper/inducer and cytotoxic/suppressor subpopulations in mouse and 
man, J. Exp. Med.  153:310-323. 
15.  Brodsky,  F. M. 1984. A matrix approach to human Class 1I histocompatibility antigens: 
reactions of four monoclonal antibodies with the products of nine haplotypes,  lmmu- 
nogenetics.  19:179-194. 
16.  Oi,  V.,  P. P. Jones, J.  W. Goding,  L. A. Herzenberg and  L. A. Herzenberg.  1978. 
Properties of monoclonal antibodies to mouse Ig antigens, H-2 and la antigens.  Curr. 
Top. Microbiol.  lmmunol.  81:115-129. 
17.  Parham, P., M. J. Androlewicz,  F. M. Brodsky, N. J. Holmes, and J. P. Ways. 1982. 
Monoelonal antibodies: purification, fragmentation, and application  to structural and 
functional studies of Class I MHC antigens. Z  lmmunol. Methods. 53:133-173. 
18.  Brodsky,  F. M.  1984. Biochemical characterization of cell surface antigens with mono- 
clonal  antibodies.  In Lymphocyte Surface Antigens 1984. E.  Heise, editor. American 
Society for Histocompatibility and [mmunogenetics Press, New York. 69-102. 
19.  Parham, P.,  and H. L. Ploegh.  1980. Molecular characterization  of HLA-A,B homo- 
logues in owl monkeys and other non-human primates, lmmunogenetics.  11:131-143. 
20.  Krangel, M. S., H. T. Orr, and J.  L. Strominger.  1979. Assembly and maturation  of 
HLA-A and HLA-B antigens in vivo. Cell.  18:979-991. 
2 I.  van Agthoven, A., C. Terhorst, E. Reinherz, and S. Schlossman. 198 I. Characterization 
of T cell surface glycoproteins TI and T3 present on all human peripheral  T lymphocytes 
and functionally mature thymocytes. Eur J. lmmunol.  11:18-21. 
22.  Tolleshaug,  H., J. L. Goldstein, W. J. Schneider,  and M. S. Brown.  1982. Posttransla- 
tional processing of the LDL receptor and its genetic disruption in familial hypercholes- 
terolemia. Cell. 30:7 l 5-724. 
23.  Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head 
of bacteriophage T4. Nature (Lond.).  227:680-685. 
24.  Pearse,  B. M.  F.,  and  M.  S.  Robinson.  1984. Purification and  properties  of 100-kd 
proteins from coated vesicles and their reconstitution with clathrin. EMBO (Eur Mol. 
BioL Organ.) J. 3:1951-1957. 
25.  Brodsky,  F.  M., and  P.  Parham.  1983. Polymorphism in clathrin  light chains  from 
different tissues..L Mol. Biol.  167:197-204. 
26.  Holmes,  N.,  S.  J.  Biermann,  F.  M.  Brodsky,  B.  Bharucha,  and  P.  Parham.  1984. 
Comparison of the primary structures of clathrin  light chains from bovine brain and 
adrenal gland by peptide mapping. EMBO (Eur.  MoL Biol.  Organ.) J. 3:1621-1627. 
27.  Rosa, F., M. Fellous,  M. Dron, M. Tovey, and M. Revel. 1983. Presence of an abnormal 
#2-microglobulin  mRNA  in  Daudi  cells:  induction  by  interferon,  lmmunogenetics. 
17:141-146. 
28.  Blikstad,  I., and E. Lazarides.  1983. Vimentin filaments are assembled from a soluble 
precursor in avian erythroid cells. J. Cell BioL 96:1803-1808. 
29.  Blikstad,  I., W. J. Nelson, R. T. Moon, and E. Lazarides.  1983. Synthesis and assemby 
of spectrin during avian erythropoiesis:  stoichiometric assembly but unequal  synthesis 
ofc~ and # spectrin.  Cell. 32:1081-1091. 
30.  Blikstad,  I.,  and  E.  Lazarides.  1983. Synthesis of spectrin  in  avian erythroid  ceils: 
association of nascent polypaptide  chains with the cytoskeleton.  Proc. Natk Acad Sci. 
USA. 80:2637-2641. 
31.  Winkler, F. K., and K. K. Stanley.  1983. Clathrin heavy chain, light chain interaction. 
EMBO (  Eur. Mol. Biol.  Organ.),L  2:1393-1400. 
2062  THE  JOURNAL OF  CELL BIOLOGY - VOLUME  101,  1985 